{"Abbreviation":"5-MeO-DiPT","Aliases":["5-MeO-DIPT","Foxy methoxy","5-methoxy-N,N-bis(1-methylethyl)-1H-Indole-3-ethanamine","Methoxy Foxy","1H-Indole-3-ethanamine, 5-methoxy-N,N-bis(1-methylethyl)-","N-isopropyl-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)propan-2-amine","N-(1-methylethyl)-N-{2-[5-(methyloxy)-1H-indol-3-yl]ethyl}propan-2-amine","N-isopropyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine","3-[2-(diisopropylamino)ethyl]-5-methoxyindole","N-{2-[5-(methyloxy)-1H-indol-3-yl]ethyl}-N-(propan-2-yl)propan-2-amine"],"CAS":"4021-34-5","ChEBI":"CHEBI:48282","ChEMBL":"CHEMBL2140942","ChemicalClasses":["tryptamine"],"Chirality":"achiral","Classes":null,"DEA no":7439,"Dosing Info":[],"DrugClasses":["psychedelic"],"DurationOfAction":"4–8 hours","EliminationHalfLife":"","European Community (EC) Number":"110-145-2","FullSalts":["5-Methoxy-N,N-diisopropyltryptamine hydrochloride"],"HMDB ID":"HMDB0246642","HeavyAtomCount":20,"IUPACName":"N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propan-2-ylpropan-2-amine","InChI":"InChI=1S/C17H26N2O/c1-12(2)19(13(3)4)9-8-14-11-18-17-7-6-15(20-5)10-16(14)17/h6-7,10-13,18H,8-9H2,1-5H3","InChIKey":"DNBPMBJFRRVTSJ-UHFFFAOYSA-N","MolecularFormula":"C\u003csub\u003e17\u003c/sub\u003eH\u003csub\u003e26\u003c/sub\u003eN\u003csub\u003e2\u003c/sub\u003eO","MolecularWeight":"274.4 g/mol","PD":"PD008862","Pharmacodynamics":"5-methoxy-diisopropyltryptamine, also known as 5-methoxy-N,N-diisopropyltryptamine, 5-MeO-DiPT, foxy methoxy, or just foxy, is a tryptamine that is used recreationally as a psychedelic. 5-MeO-DiPT is orally active, and dosages between 6–20 mg are commonly reported. Many users note an unpleasant body load accompanies higher dosages. 5-MeO-DiPT is also taken by insufflation, or sometimes it is smoked or injected. Some users also report sound distortion, also noted with the related drug, DiPT.","PrevSalts":["hydrochloride"],"PubChemId":151182,"Record Description":["5-methoxy-N,N-diisopropyltryptamine is a member of tryptamines. It has a role as a hallucinogen. It is functionally related to a N,N-diisopropyltryptamine and a 5-methoxytryptamine.","5-methoxy-N,N-diisopropyltryptamine is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Hallucinogenic substances substance.","5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine, N,N-diethyltryptamine, bufotenine, psilocybin and psilocin. Since 1999, there has been a growing popularity of 5-MeO-DIPT among drug abusers. This substance is abused for its hallucinogenic effects.","5-methoxy-N,N-diisopropyltryptamine is a member of tryptamines. It has a role as a hallucinogen. It is functionally related to a N,N-diisopropyltryptamine and a 5-methoxytryptamine.","Wikipedia|List of designer drugs|Psychedelics|Tryptamines","Wikipedia|TiHKAL|Tryptamines"],"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/5-MeO-DiPT","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q2983762","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB01441","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/151182","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2140942","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:48282","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"Probes \u0026 Drugs","Urls":[{"Link":"https://www.probes-drugs.org/compound/PD008862","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=4021-34-5","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0246642","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/C22724","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/12D06G8W8E","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID00193209","Name":"5-Methoxy-N,N-diisopropyltryptamine","Sub":false}]}],"SMILES":"CC(C)N(CCC1=CNC2=C1C=C(C=C2)OC)C(C)C","Salts":["hydrochloride"],"SaltsAcidCount":[1],"SaltsAmineCount":[1],"SaltsUNII":["SJ048VQB9S"],"Scheduling":[{"gov":"Brazil","schedule":"F2 substance"},{"gov":"Canada","schedule":"Unscheduled substance"},{"gov":"United Kingdom","schedule":"Class A substance"},{"gov":"United States","schedule":"Schedule I substance"},{"gov":"Germany","schedule":"Anlage I substance"},{"gov":"United Nations","schedule":"Unscheduled substance"}],"StoreUNII":["12D06G8W8E"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="63.847mm" version="1.2" viewBox="0 0 121.182 63.847" width="121.182mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#3050F8" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="64.0" stroke="none" width="122.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="120.144" x2="106.937" y1="35.026" y2="42.63"/>
                  
            <line class="bond" id="mol1bnd2" x1="106.937" x2="106.918" y1="42.63" y2="57.87"/>
                  
            <line class="bond" id="mol1bnd3" x1="106.937" x2="96.9" y1="42.63" y2="36.819"/>
                  
            <line class="bond" id="mol1bnd4" x1="90.594" x2="80.54" y1="36.81" y2="42.598"/>
                  
            <line class="bond" id="mol1bnd5" x1="80.54" x2="67.352" y1="42.598" y2="34.962"/>
                  
            <line class="bond" id="mol1bnd6" x1="67.352" x2="54.144" y1="34.962" y2="42.565"/>
                  
            <g class="bond" id="mol1bnd7">
                        
                <line x1="52.562" x2="54.144" y1="57.684" y2="42.565"/>
                        
                <line x1="50.322" x2="51.535" y1="55.666" y2="44.067"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd8" x1="52.562" x2="41.002" y1="57.684" y2="60.135"/>
                  
            <line class="bond" id="mol1bnd9" x1="35.564" x2="30.022" y1="57.177" y2="47.642"/>
                  
            <g class="bond" id="mol1bnd10">
                        
                <line x1="30.022" x2="40.22" y1="47.642" y2="36.317"/>
                        
                <line x1="29.152" x2="37.465" y1="44.964" y2="35.732"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd11" x1="54.144" x2="40.22" y1="42.565" y2="36.317"/>
                  
            <line class="bond" id="mol1bnd12" x1="40.22" x2="35.503" y1="36.317" y2="21.816"/>
                  
            <g class="bond" id="mol1bnd13">
                        
                <line x1="35.503" x2="20.589" y1="21.816" y2="18.641"/>
                        
                <line x1="33.619" x2="21.459" y1="23.908" y2="21.319"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd14" x1="20.589" x2="10.391" y1="18.641" y2="29.967"/>
                  
            <g class="bond" id="mol1bnd15">
                        
                <line x1="10.391" x2="15.108" y1="29.967" y2="44.467"/>
                        
                <line x1="13.146" x2="16.992" y1="30.552" y2="42.375"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd16" x1="30.022" x2="15.108" y1="47.642" y2="44.467"/>
                  
            <line class="bond" id="mol1bnd17" x1="20.589" x2="17.121" y1="18.641" y2="7.962"/>
                  
            <line class="bond" id="mol1bnd18" x1="12.253" x2=".975" y1="3.374" y2=".975"/>
                  
            <line class="bond" id="mol1bnd19" x1="93.753" x2="93.767" y1="31.144" y2="19.754"/>
                  
            <line class="bond" id="mol1bnd20" x1="93.767" x2="106.974" y1="19.754" y2="12.15"/>
                  
            <line class="bond" id="mol1bnd21" x1="93.767" x2="80.578" y1="19.754" y2="12.118"/>
                  
            <path class="atom" d="M95.689 37.444h-.721l-2.619 -4.066h-.03q.012 .238 .03 .595q.024 .357 .024 .732v2.739h-.566v-4.9h.715l2.607 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.483v-2.768h.578v4.9z" id="mol1atm4" stroke="none"/>
                  
            <g class="atom" id="mol1atm9">
                        
                <path d="M39.633 63.287h-.721l-2.619 -4.066h-.03q.012 .238 .03 .595q.024 .357 .024 .732v2.739h-.566v-4.9h.715l2.607 4.055h.03q-.006 -.108 -.018 -.328q-.012 -.22 -.024 -.476q-.006 -.262 -.006 -.482v-2.769h.578v4.9z" stroke="none"/>
                        
                <path d="M35.189 63.287h-.619v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.619v4.9z" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M18.141 4.143q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.245 -.572 -.245 -1.334q.0 -.75 .245 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.732 .0 1.232 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM14.277 4.143q.0 .923 .387 1.459q.393 .53 1.221 .53q.839 -.0 1.22 -.53q.387 -.536 .387 -1.459q-.0 -.928 -.387 -1.452q-.381 -.524 -1.208 -.524q-.834 -.0 -1.227 .524q-.393 .524 -.393 1.452z" fill="#FF0D0D" id="mol1atm16" stroke="none"/>
                
            <line class="hi" id="mol1bnd3" stroke="#3050F8" x1="96.9" x2="101.9185" y1="36.819" y2="39.724500000000006"/>
            <line class="hi" id="mol1bnd4" stroke="#3050F8" x1="90.594" x2="85.56700000000001" y1="36.81" y2="39.704"/>
            <line class="hi" id="mol1bnd8" stroke="#3050F8" x1="41.002" x2="46.782" y1="60.135" y2="58.909499999999994"/>
            <line class="hi" id="mol1bnd8" stroke="#3050F8" x1="41.002" x2="46.782" y1="60.135" y2="58.909499999999994"/>
            <line class="hi" id="mol1bnd9" stroke="#3050F8" x1="35.564" x2="32.793" y1="57.177" y2="52.4095"/>
            <line class="hi" id="mol1bnd9" stroke="#3050F8" x1="35.564" x2="32.793" y1="57.177" y2="52.4095"/>
            <line class="hi" id="mol1bnd17" stroke="#FF0D0D" x1="17.121" x2="18.854999999999997" y1="7.962" y2="13.301499999999999"/>
            <line class="hi" id="mol1bnd18" stroke="#FF0D0D" x1="12.253" x2="6.614" y1="3.374" y2="2.1745"/>
            <line class="hi" id="mol1bnd19" stroke="#3050F8" x1="93.753" x2="93.75999999999999" y1="31.144" y2="25.448999999999998"/>
        </g>
          
    </g>
    
</svg>
","Title":"5-Methoxy-N,N-diisopropyltryptamine","UNII":"12D06G8W8E","Wikidata":"Q2983762","Wikipedia":"5-MeO-DiPT","XLogP":3.1}